- Home
- RVPH vs CLIR Comparison
RVPH vs CLIR Comparison
Compare RVPH & CLIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- CLIR
- Stock Information
- Founded
- RVPH 2006
- CLIR 2008
- Country
- RVPH United States
- CLIR United States
- Employees
- RVPH N/A
- CLIR N/A
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- CLIR Industrial Machinery/Components
- Sector
- RVPH Health Care
- CLIR Industrials
- Exchange
- RVPH Nasdaq
- CLIR Nasdaq
- Market Cap
- RVPH 30.1M
- CLIR 30.7M
- IPO Year
- RVPH N/A
- CLIR 2012
- Fundamental
- Price
- RVPH $0.40
- CLIR $0.51
- Analyst Decision
- RVPH Strong Buy
- CLIR Strong Buy
- Analyst Count
- RVPH 5
- CLIR 1
- Target Price
- RVPH $5.20
- CLIR $2.00
- AVG Volume (30 Days)
- RVPH 1.3M
- CLIR 89.1K
- Earning Date
- RVPH 11-13-2025
- CLIR 11-13-2025
- Dividend Yield
- RVPH N/A
- CLIR N/A
- EPS Growth
- RVPH N/A
- CLIR N/A
- EPS
- RVPH N/A
- CLIR N/A
- Revenue
- RVPH N/A
- CLIR $2,983,000.00
- Revenue This Year
- RVPH N/A
- CLIR $13.13
- Revenue Next Year
- RVPH N/A
- CLIR $143.88
- P/E Ratio
- RVPH N/A
- CLIR N/A
- Revenue Growth
- RVPH N/A
- CLIR 19.03
- 52 Week Low
- RVPH $0.30
- CLIR $0.46
- 52 Week High
- RVPH $4.28
- CLIR $1.72
- Technical
- Relative Strength Index (RSI)
- RVPH 34.75
- CLIR 34.97
- Support Level
- RVPH $0.50
- CLIR $0.46
- Resistance Level
- RVPH $0.47
- CLIR $0.57
- Average True Range (ATR)
- RVPH 0.03
- CLIR 0.03
- MACD
- RVPH -0.01
- CLIR -0.01
- Stochastic Oscillator
- RVPH 14.30
- CLIR 31.80
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.
About CLIR ClearSign Technologies Corporation (DE)
ClearSign Technologies Corp is engaged in providing solutions to some of the pressing productivity, energy efficiency, and pollution problems affecting the energy, oil, and gas production, boiler, and processing industries. It believes that its patented ClearSign Core technology can enhance the performance of combustion systems in a broad range of markets, including the energy (upstream oil production and downstream refining), institutional, commercial, and industrial boiler, chemical, and petrochemical industries. The company offers products that include process burners, boiler burners, flares, and ClearSign Eye.